Herbal Medicines: challenges in the modern world. Part 5. status and current directions of complementary and alternative herbal medicine worldwide

References

• Smith T, Lynch ME, Johnson J, et al. Herbal dietary supplement sales in us increase 6.8% in 2014. Herbalgram Am Bot Counc. 2015;107:52–59. Available from: http://cms.herbalgram.org/herbalgram/issue107/hg107-mktrpt-2014hmr.html
   Google Scholar
• World Health Organization. WHO traditional medicine strategy: 2014-2023; [cited 2016Oct 20]. Available from: http://apps.who.int/iris/bitstream/10665/92455/1/9789241506090_eng.pdf
   Google Scholar
• DSM Group. Pharmaceutical market in Russia; May 2014 [cited 2016 Oct 20]. Available from: http://www.dsm.ru/docs/analytics/spravka_may_2014.pdf. Russian.
   Google Scholar
• Nilsson M, Trehn G, Asplund K. Use of complementary and alternative medicine remedies in Sweden. A population‐based longitudinal study within the northern Sweden MONICA Project. J Intern Med. 2001;250:225–233.
   PubMed Web of Science ®Google Scholar
• Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States–prevalence, costs, and patterns of use. New England J Med. 1993;328:246–252.
   PubMed Web of Science ®Google Scholar
• Burg MA, Hatch RL, Neims AH. Lifetime use of alternative therapy: a study of Florida residents. South Med J. 1998;91:1126–1131.
   PubMed Web of Science ®Google Scholar
• Stussman BJ, Black LI, Barnes PM, et al. Wellness-related use of common complementary health approaches among adults: United States, 2012. Natl Health Stat Report. 2015;85:1–12.
   Google Scholar
• Treister-Goltzman Y, Peleg R. Trends in publications on complementary and alternative medicine in the medical literature. J Complement Integr Med. 2015;12:111–115.
   PubMedGoogle Scholar
• Teng L, Zu Q, Li G, et al. Herbal medicines: challenges in the modern world. Part 3. China and Japan. Expert Rev Clin Pharmacol. 2016;9:1225–1233.
   PubMed Web of Science ®Google Scholar
• Job KM, Kiang TK, Constance JE, et al. Herbal medicines: challenges in the modern world. Part 4. Canada and United States. Expert Rev Clin Pharmacol. 2016;9(12):1–13.
   PubMed Web of Science ®Google Scholar
• Barnes J, McLachlan AJ, Sherwin CM, et al. Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand. Expert Rev Clin Pharmacol. 2016;9:905–915.
   PubMed Web of Science ®Google Scholar
• Sammons HM, Gubarev MI, Krepkova LV, et al. Herbal medicines: challenges in the modern world. Part 2. European Union and Russia. Expert Rev Clin Pharmacol. 2016;9:1117–1127.
   PubMed Web of Science ®Google Scholar
• Liu M, Zhong X, Li Y, et al. Xuan Bai Cheng Qi formula as an adjuvant treatment of acute exacerbation of chronic obstructive pulmonary disease of the syndrome type phlegm-heat obstructing the lungs: a multicenter, randomized, double-blind, placebo-controlled clinical trial. BMC Complement Altern Med. 2014;14:239.
   PubMed Web of Science ®Google Scholar
• Shi L, Xie Y, Liao X, et al. Shenmai injection as an adjuvant treatment for chronic cor pulmonale heart failure: a systematic review and meta-analysis of randomized controlled trials. BMC Complement Altern Med. 2015;15:418.
   PubMed Web of Science ®Google Scholar
• Ling Y. Traditional Chinese medicine in the treatment of symptoms in patients with advanced cancer. Ann Palliat Med. 2013;2:141–152.
   PubMedGoogle Scholar
• Data talk: 2015 Big pharmaceutical retail market characteristics. [cited 2016 Oct 20]. Available from: http://news.mypharma.com/guandian/fx/20173.html
   Google Scholar
• Liu X, Lin T-F. Application progress on the development of functional beverages with medicinal edible Chinese herbs. Anhui Agricultural Sciences. 2015;43:81–84.
   Google Scholar
• Black LI, Clarke TC, Barnes PM, et al. Use of complementary health approaches among children aged 41-7 years in the United States: National Health Interview Survey, 2007-2012. Natl Health Stat Report. 2015;78:1–19.
   Google Scholar
• Hakamatsuka T. Revision of Kampo extra formulae that recorded in Japanese pharmacopoeia and standard approval for OTC Kampo products (in Japanese). Farumashia. 2011;47:413–417.
   Google Scholar
• Zhang AL, Story DF, Lin V, et al. A population survey on the use of 24 common medicinal herbs in Australia. Pharmacoepidemiol Drug Saf. 2008;17:1006–1013.
   PubMed Web of Science ®Google Scholar
• Nicholson T. Complementary and alternative medicines (including traditional Maori treatments) used by presenters to an emergency department in New Zealand: a survey of prevalence and toxicity. N Z Med J. 2006;119:U1954.
   PubMedGoogle Scholar
• Zuzak TJ, Bonkova J, Careddu D, et al. Use of complementary and alternative medicine by children in Europe: published data and expert perspectives. Complement Ther Med. 2013;21(Suppl 1):S34–47.
   PubMed Web of Science ®Google Scholar
• Newmaster SG, Grguric M, Shanmughanandhan D, et al. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med. 2013;11:222.
   PubMed Web of Science ®Google Scholar
• Gahche J, Bailey R, Burt V, et al. Dietary supplement use among U.S adults has increased since NHANES III (1988–1994). NCHS Data Brief. 2011 Apr;61:1–8.
   PubMedGoogle Scholar
• Wu C-H, Wang -C-C, Kennedy J. The prevalence of herb and dietary supplement use among children and adolescents in the United States: results from the 2007 National Health Interview Survey. Complement Ther Med. 2013;21:358–363.
   PubMed Web of Science ®Google Scholar
• Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med. 2008;23(6):854–859.
   PubMed Web of Science ®Google Scholar
• Kennedy J. Herb and supplement use in the US adult population. Clin Ther. 2005;27:1847–1858.
   PubMed Web of Science ®Google Scholar
• Ipsos Reid. Natural Health Product Tracking Survey – 2010. Final Report. Prepared for Health Canada. [cited 2016 Oct 20]. Available from: http://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2011/135-09/report.pdf
   Google Scholar
• Vickers A, Zollman C. Herbal medicine. Bmj. 1999;319:1050–1053.
   PubMed Web of Science ®Google Scholar
• Morgan AJ, Francis AJ. Australian natural therapists and mental health: survey of treatment approaches and referral patterns. J Complement Integr Med. 2008;5(1): Art 24; doi:10.2202/1553-3840.1132
   Google Scholar
• Marcus DM. How should alternative medicine be taught to medical students and physicians? Acad Med. 2001;76:224–229.
   PubMed Web of Science ®Google Scholar
• Jump J, Yarbrough L, Kilpatrick S, et al. Physicians’ attitudes toward complementary and alternative medicine. Integr Med. 1998;1:149–153.
   Google Scholar
• Mikail CN, Hearney E, Nemesure B. Increasing physician awareness of the common uses and contraindications of herbal medicines: utility of a case-based tutorial for residents. J Altern Complement Med. 2003;9:571–576.
   PubMed Web of Science ®Google Scholar
• Wahner-Roedler DL, Vincent A, Elkin PL, et al. Physicians’ attitudes toward complementary and alternative medicine and their knowledge of specific therapies: a survey at an academic medical center. J Evid Based Complementary Altern Med. 2006;3:495–501.
   Google Scholar
• MacLennan AH, Wilson DH, Taylor AW. The escalating cost and prevalence of alternative medicine. Prev Med. 2002;35:166–173.
   PubMed Web of Science ®Google Scholar
• Gardiner P, Graham R, Legedza ATR, et al. Factors associated with herbal therapy use by adults in the United States. Altern Ther Health Med. 2007;13:22–29.
   PubMed Web of Science ®Google Scholar
• Yoon SJL, Horne CH. Herbal products and conventional medicines used by community‐residing older women. J Adv Nurs. 2001;33:51–59.
   PubMed Web of Science ®Google Scholar
• O’Hara M, Kiefer D, Farrell K, et al. A review of 12 commonly used medicinal herbs. Arch Fam Med. 1998;7:523.
   PubMedGoogle Scholar
• Pirri C. Integrating complementary and conventional medicine. Cancer Forum. 2011:35(1):31–39.
   Google Scholar
• Coss RA, McGrath P, Caggiano V. Alternative care patient choices for adjunct therapies within a cancer center. Cancer Pract. 1998;6:176–181.
   PubMedGoogle Scholar
• NZ Ministry of Health. Natural health and supplementary products. [cited 2016 Oct 20]. Available from: http://www.health.govt.nz/our-work/regulation-health-and-disability-system/natural-health-and-supplementary-products
   Google Scholar
• Jong MC, Van De Vijver L, Busch M, et al. Integration of complementary and alternative medicine in primary care: what do patients want? Patient Educ Couns. 2012;89:417–422.
   PubMed Web of Science ®Google Scholar
• Japan Kampo Medicines Manufacturers Association (JKMA). [cited 2016 Oct 20]. Available from: http://www.nikkankyo.org/index.html.
   Google Scholar
• Pradeep A, Garg V, Raju A, et al. adjunctive local delivery of aloe vera gel in type 2 diabetics with chronic periodontitis: a randomized controlled clinical trial. J Periodontol. 2016;87(3):268–274.
   Google Scholar
• Aruoma OI, Somanah J, Bourdon E, et al. Diabetes as a risk factor to cancer: functional role of fermented papaya preparation as phytonutraceutical adjunct in the treatment of diabetes and cancer. Mutat Res Fund Mol Mech Mut. 2014;768:60–68.
   PubMed Web of Science ®Google Scholar
• Uehleke B, Ortiz M, Stange R. cholesterol reduction using psyllium husks–do gastrointestinal adverse effects limit compliance? Results of a specific observational study. Phytomedicine. 2008;15:153–159.
   PubMed Web of Science ®Google Scholar
• Man SC, Durairajan S, Kum WF, et al. Systematic review on the efficacy and safety of herbal medicines for Alzheimer’s disease. J Alzheimers Dis. 2008;14:209–223.
   PubMed Web of Science ®Google Scholar
• Sarris J, Kavanagh DJ, Byrne G. Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines. J Psychiatr Res. 2010;44:32–41.
   PubMed Web of Science ®Google Scholar
• Chung V, Liu L, Bian Z, et al. Efficacy and safety of herbal medicines for idiopathic Parkinson’s disease: a systematic review. Move Disorders. 2006;21:1709–1715.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). antibiotic resistance threats in the United States; CDC: Atlanta, GA, USA, 2013. [cited 2016 Oct 20]. Available from: http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf .
   Google Scholar
• Dashtdar M, Dashtdar MR, Dashtdar B, et al. Phenol-rich compounds sweet gel: a statistically more effective antibiotic than cloxacillin against pseudomonas aeruginosa. J Pharmacopuncture. 2016;19:246–252.
   PubMed Web of Science ®Google Scholar
• Golestani MR, Rad M, Bassami M, et al. Analysis and evaluation of antibacterial effects of new herbal formulas, AP-001 and AP-002, against Escherichia coli O157:H7. Life Sci. 2015;135:22–26.
   PubMed Web of Science ®Google Scholar
• Tsouh Fokou PV, Nyarko AK, Appiah-Opong R, et al. Update on medicinal plants with potency on mycobacterium ulcerans. Biomed Res Int. 2015;2015:917086.
   PubMed Web of Science ®Google Scholar
• Komlaga G, Agyare C, Dickson RA, et al. Medicinal plants and finished marketed herbal products used in the treatment of malaria in the Ashanti region, Ghana. J Ethnopharmacol. 2015;172:333–346.
   PubMed Web of Science ®Google Scholar
• Vichkanova SA, Fateeva TV, Krutikova NM, et al. Sanquiritrin. Gift of nature to humans. Moscow: OneBook.ru; 2015.
   Google Scholar
• Krishnavignesh L, Mahalakshmipriya A, Ramesh M. In vitro analysis of phytochemical screening and antimicrobial activity of parthenium hysterophorus l. Against pathogenic microorganisms. Asian J Pharm Clin Res. 2013;6:41–44.
   Google Scholar
• Karygianni L, Cecere M, Skaltsounis AL, et al. High-level antimicrobial efficacy of representative Mediterranean natural plant extracts against oral microorganisms. Biomed Res Int. 2014;2014:839019.
   PubMed Web of Science ®Google Scholar
• Paraschos S, Magiatis P, Mitakou S, et al. In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori. Antimicrob Agents Chemother. 2007;51:551–559.
   PubMed Web of Science ®Google Scholar
• Dictionary of Natural Products on DVD v.23:1. CRC Press; Boca Raton, FL, USA: 2014.
   Google Scholar
• Snow Setzer M, Sharifi-Rad J, Setzer WN. The search for herbal antibiotics: an in-silico investigation of antibacterial phytochemicals. Antibiotics (Basel). 2016;5(3). pii: E30. doi:10.3390/antibiotics5030030
   PubMed Web of Science ®Google Scholar
• Geller AI, Shehab N, Weidle NJ, et al. Emergency department visits for adverse events related to dietary supplements. N Engl J Med. 2015;373:1531–1540.
   PubMed Web of Science ®Google Scholar
• Shen J, Mo X, Tang Y, et al. Analysis of herb-herb interaction when decocting together by using ultra-high-performance liquid chromatography-tandem mass spectrometry and fuzzy chemical identification strategy with poly-proportion design. J Chromatogr A. 2013;1297:168–178.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lin Y, Zhao H, et al. Revealing the effects of the herbal pair of euphorbia kansui and glycyrrhiza on hepatocellular carcinoma ascites with integrating network target analysis and experimental validation. Int J Biol Sci. 2016;12:594–606.
   PubMed Web of Science ®Google Scholar
• Fan Y, Man S, Li H, et al. Analysis of bioactive components and pharmacokinetic study of herb-herb interactions in the traditional Chinese patent medicine Tongmai Yangxin Pill. J Pharm Biomed Anal. 2016;120:364–373.
   PubMed Web of Science ®Google Scholar
• Hu PY, Yue PF, Zheng Q, et al. Pharmacokinetic comparative study of gastrodin after oral administration of Gastrodia elata Bl. extract and its compatibility with the different indigents of Ligusticum chuanxiong Hort. to rats. J Ethnopharmacol. 2016;191:82–86.
   PubMed Web of Science ®Google Scholar
• Gong C, Yang H, Wei H, et al. Pharmacokinetic comparisons by UPLC-MS/MS of isomer paeoniflorin and albiflorin after oral administration decoctions of single-herb Radix Paeoniae Alba and Zengmian Yiliu prescription to rats. Biomed Chromatogr. 2015;29:416–424.
   PubMed Web of Science ®Google Scholar
• Bunel V, Antoine MH, Nortier J, et al. In vitro effects of panax ginseng in aristolochic acid-mediated renal tubulotoxicity: apoptosis versus regeneration. Planta Med. 2015;81:363–372.
   PubMed Web of Science ®Google Scholar
• Jeong TY, Park BK, Cho JH, et al. A prospective study on the safety of herbal medicines, used alone or with conventional medicines. J Ethnopharmacol. 2012;143:884–888.
   PubMed Web of Science ®Google Scholar
• Choi JG, Eom SM, Kim J, et al. A comprehensive review of recent studies on herb-drug interaction: a focus on pharmacodynamic interaction. J Altern Complement Med. 2016;22:262–279.
   PubMed Web of Science ®Google Scholar
• Neergheen-Bhujun VS. Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries. Biomed Res Int. 2013;2013:804086.
   PubMed Web of Science ®Google Scholar
• Haefeli WE, Carls A. Drug interactions with phytotherapeutics in oncology. Expert Opin Drug Metab Toxicol. 2014;10:359–377.
   PubMed Web of Science ®Google Scholar
• Davis EL, Oh B, Butow PN, et al. Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. Oncologist. 2012;17:1475–1481.
   PubMed Web of Science ®Google Scholar
• Richardson MA, Sanders T, Palmer JL, et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18:2505–2514.
   PubMed Web of Science ®Google Scholar
• Fernandez CV, Stutzer CA, MacWilliam L, et al. Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse. J Clin Oncol. 1998;16:1279–1286.
   PubMed Web of Science ®Google Scholar
• Neuhouser ML, Patterson RE, Schwartz SM, et al. Use of alternative medicine by children with cancer in Washington state. Prev Med. 2001;33:347–354.
   PubMed Web of Science ®Google Scholar
• Laengler A, Spix C, Seifert G, et al. Complementary and alternative treatment methods in children with cancer: A population-based retrospective survey on the prevalence of use in Germany. Eur J Cancer. 2008;44:2233–2240.
   PubMed Web of Science ®Google Scholar
• Quimby EL. The use of herbal therapies in pediatric oncology patients: treating symptoms of cancer and side effects of standard therapies. J Pediatr Oncol Nurs. 2007;24:35–40.
   PubMed Web of Science ®Google Scholar
• Bernstein BJ, Grasso T. Prevalence of complementary and alternative medicine use in cancer patients. Oncology (Williston Park). 2001;15:1267-1272;discussion 1272-1268, 1283.
   PubMed Web of Science ®Google Scholar
• Stargrove MB, Treasure J, McKee DL. Herb, Nutrient, and Drug Interactions. Clinical Implications and Therapeutic Strategies. St. Louis: Mosby Elsevier; 2008.
   Google Scholar
• Haouala A, Widmer N, Duchosal MA, et al. Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib. Blood. 2011;117:e75–87.
   PubMed Web of Science ®Google Scholar
• Gligorov J, Lotz JP. Preclinical pharmacology of the taxanes: implications of the differences. Oncologist. 2004;9(Suppl 2):3–8.
   PubMed Web of Science ®Google Scholar
• Bauer S, Stormer E, Johne A, et al. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John’s wort in renal transplant patients. Br J Clin Pharmacol. 2003;55:203–211.
   PubMed Web of Science ®Google Scholar
• Mai I, Stormer E, Bauer S, et al. Impact of St John’s wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients. Nephrol Dial Transplant. 2003;18:819–822.
   PubMed Web of Science ®Google Scholar
• Jendzelovska Z, Jendzelovsky R, Kucharova B, et al. Hypericin in the light and in the dark: two sides of the same coin. Front Plant Sci. 2016;7:560.
   PubMed Web of Science ®Google Scholar
• Percival SS. Use of echinacea in medicine. Biochem Pharmacol. 2000;60:155–158.
   PubMed Web of Science ®Google Scholar
• Kumar KM, Ramaiah S. Pharmacological importance of Echinacea Purpurea. Int J Pharma Bio Sci. 2011 Oct-Dec;2:304–314.
   Google Scholar
• Budzinski JW, Foster BC, Vandenhoek S, et al. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine. 2000;7:273–282.
   PubMed Web of Science ®Google Scholar
• Yale SH, Glurich I. Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J Altern Complement Med. 2005;11:433–439.
   PubMed Web of Science ®Google Scholar
• Gorski JC, Huang SM, Pinto A, et al. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther. 2004;75:89–100.
   PubMed Web of Science ®Google Scholar
• Haria EN, Perera MADN, Senchina DS. Immunomodulatory effects of Echinacea laevigata ethanol tinctures produced from different organs. Biosci Horizons. 2016;9. doi:10.1093/biohorizons/hzw1001
   Google Scholar
• Park YJ, Ahn HY, Kim HR, et al. Ginkgo biloba extract EGb 761-mediated inhibition of aromatase for the treatment of hormone-dependent breast cancer. Food Chem Toxicol. 2016;87:157–165.
   PubMed Web of Science ®Google Scholar
• Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: united States, 2007.Natl Health Stat Report. 2008;12:1–23.
   Google Scholar
• Yi SY, Nan KJ, Chen SJ. [Effect of extract of Ginkgo biloba on doxorubicin-associated cardiotoxicity in patients with breast cancer]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28:68–70.
   PubMedGoogle Scholar
• Hasegawa H, Sung JH, Matsumiya S, et al. Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids. Planta Med. 1995;61:409–413.
   PubMed Web of Science ®Google Scholar
• Monakhov BV. Extract of Eleutherococcus senticosus maxim and the therapeutic activity of cyclophosphane, ethymidine, and benzo-TEPA. Vopr Onkol. 1967;13:94–97.
   PubMedGoogle Scholar
• Monakhov BV. [Reduction of the toxic effect of various antiblastic preparations by means of Eleutherococcus extract]. Vopr Onkol. 1967;13:71–76.
   PubMedGoogle Scholar
• Braakhuis AJ, Campion P, Bishop KS. Reducing breast cancer recurrence: the role of dietary polyphenolics. Nutrients. 2016;8(9). pii: E547. doi:10.3390/nu8090547
   Web of Science ®Google Scholar
• Liang YC, Lin-Shiau SY, Chen CF, et al. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem. 1997;67:55–65.
   PubMed Web of Science ®Google Scholar
• Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 2003;43:89–143.
   PubMed Web of Science ®Google Scholar
• Misaka S, Kawabe K, Onoue S, et al. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes. Drug Metab Pharmacokinet. 2013;28:244–249.
   PubMed Web of Science ®Google Scholar
• Turkmenoglu FP, Kutsal YG, Dolgun AB, et al. Evaluation of herbal product use and possible herb-drug interactions in Turkish elderly. Complement Ther Clin Pract. 2016;23:46–51.
   PubMed Web of Science ®Google Scholar
• Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. Jama. 2002;287:337–344.
   PubMed Web of Science ®Google Scholar
• De Souza Silva JE, Santos Souza CA, Da Silva TB, et al. Use of herbal medicines by elderly patients: a systematic review. Arch Gerontol Geriatr. 2014;59:227–233.
   PubMed Web of Science ®Google Scholar
• Elmer GW, Lafferty WE, Tyree PT, et al. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. Ann Pharmacother. 2007;41:1617–1624.
   PubMed Web of Science ®Google Scholar
• Phelps K, Hassed C. Herb-Drug Interactions - general practice: the integrative approach series. Elsevier Health Sciences Australia. ACN 001 002 357; 2011, Chatswood, Australia.
   Google Scholar
• Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–254.
   PubMed Web of Science ®Google Scholar
• Xia S, Zhang X, Zheng S, et al. An update on inflamm-aging: mechanisms, prevention, and treatment. J Immunol Res. 2016;2016:8426874.
   PubMed Web of Science ®Google Scholar
• Shayganni E, Bahmani M, Asgary S, et al. Inflammaging and cardiovascular disease: management by medicinal plants. Phytomedicine. 2016;23:1119–1126.
   PubMed Web of Science ®Google Scholar
• Xia S, Shen Y, Yu W. Infalmm-aging related genes expression in aged rat hippocampus and Icariin intervention outcome. Geriatrics Health Care. 2008;14:340–344.
   Google Scholar
• Xia S-J, Shen Z-Y, Yu Z-W:. Study on the mechanism and intervention of inflamm-aging in rats. Chin J Gerontol. 2009;20:018.
   Google Scholar
• Rastogi S, Pandey MM, Rawat AK. Traditional herbs: a remedy for cardiovascular disorders. Phytomedicine. 2016;23:1082–1089.
   PubMed Web of Science ®Google Scholar
• Tracy TS, Korzekwa KR, Gonzalez FJ, et al. Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil. Br J Clin Pharmacol. 1999;47:545–552.
   PubMed Web of Science ®Google Scholar
• Fung WT, Subramaniam G, Lee J, et al. Assessment of extracts from red yeast rice for herb-drug interaction by in-vitro and in-vivo assays. Sci Rep. 2012;2:298.
   PubMed Web of Science ®Google Scholar
• Chen CH, Uang YS, Wang ST, et al. Interaction between red yeast rice and cyp450 Enzymes/P-Glycoprotein and its implication for the clinical pharmacokinetics of lovastatin. J Evid Based Complementary Altern Med. 2012;2012:127043.
   Google Scholar
• US Food and Drug Administration. Alternative medicine fraud. [cited 2016 Oct 20]. Available from: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/MedicationHealthFraud/ucm207747.htm
   Google Scholar
• US Food and Drug Administration. Drugs. Tainted Sexual Enhancement Products. [cited 2016 Oct 20]. Available from: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/MedicationHealthFraud/ucm234539.htm
   Google Scholar